Plunkett's Biotech & Genetics Industry Almanac 2016: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC 2016
Key Findings:
Statistical Tables Provided: 16
Companies Profiled: 399
Geographic Focus: Global
A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments.
Major Trends Affecting the Biotech & Genetics Industry
1) The State of the Biotechnology Industry Today
2) A Short History of Biotechnology
3) Ethanol Production Soared, But U.S. Federal Subsidy Expires
4) Cellulosic Ethanol Makes Slow Commercial Progress
5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
9) Vaccines and Viruses in Drug Delivery
10) New Blockbuster Drugs Come to Market/ Drug Prices Soar/Generics Offer Some Relief
11) Biotech and Orphan Drugs Create New Revenues for Drug Firms
12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs
14) Stem Cells—Multiple Sources Stem from New Technologies
15) Government Support for Stem Cell Research Evolves
16) Stem Cells—Therapeutic Cloning Techniques Advance
17) Stem Cells—A New Era of Tissue Replacement Takes Shape
18) Nanotechnology Converges with Biotech
19) Genetically Modified (GM) Seeds and Crops/R&D Investment Is High
20) Genetically Modified (GM) Ingredients in Processed or Packaged Foods
21) Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals
22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories
23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs
24) Immunotherapy Promises New Approach to Fighting Cancers
25) Technology Discussion—Genes and DNA
26) Technology Discussion—Proteins and Proteomics
27) Technology Discussion—Microarrays
28) Technology Discussion—DNA Chips
29) Technology Discussion—SNPs (“Snips”)
30) Technology Discussion—Combinatorial Chemistry
31) Technology Discussion—Synthetic Biology
32) Technology Discussion—Recombinant DNA
33) Technology Discussion—Polymerase Chain Reaction (PCR)
Biotech & Genetics Industry Statistics
1) Biotech Industry Overview
2) The U.S. Drug Discovery & Approval Process
3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2014
4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2014
5) Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2014
6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2013-2015
7) U.S. Exports & Imports of Pharmaceutical Products: 2009-1st Quarter 2015
8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2007-2023
9) Prescription Drug Expenditures, U.S.: Selected Years, 1960-2023
10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2014
11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2014-2016
12) Global Area of Biotech Crops by Country: 2014
13) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2014
14) Sales By Geographic Area, PhRMA Member Companies: 2013
15) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2014
16) Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2013
Key Findings:
- Plunkett Research lists top 400 companies in the Biotech & Genetics and names top trends changing the industry for the mid term.
- Industry trends analysis, market data and competitive intelligence
- Market forecasts and Industry Statistics
- Industry Associations and Professional Societies List
- In-Depth Profiles of hundreds of leading companies
- Industry Glossary
- Buyer may register for free access to search and export data at Plunkett Research Online
- Link to our 5-minute video overview of this industry
Statistical Tables Provided: 16
Companies Profiled: 399
Geographic Focus: Global
A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments.
- How is the industry evolving?
- How is the industry being shaped by new technologies?
- How is demand growing in emerging markets and mature economies?
- What is the size of the market now and in the future?
- What are the financial results of the leading companies?
- What are the names and titles of top executives?
- What are the top companies and what are their revenues?
Major Trends Affecting the Biotech & Genetics Industry
1) The State of the Biotechnology Industry Today
2) A Short History of Biotechnology
3) Ethanol Production Soared, But U.S. Federal Subsidy Expires
4) Cellulosic Ethanol Makes Slow Commercial Progress
5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
9) Vaccines and Viruses in Drug Delivery
10) New Blockbuster Drugs Come to Market/ Drug Prices Soar/Generics Offer Some Relief
11) Biotech and Orphan Drugs Create New Revenues for Drug Firms
12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs
14) Stem Cells—Multiple Sources Stem from New Technologies
15) Government Support for Stem Cell Research Evolves
16) Stem Cells—Therapeutic Cloning Techniques Advance
17) Stem Cells—A New Era of Tissue Replacement Takes Shape
18) Nanotechnology Converges with Biotech
19) Genetically Modified (GM) Seeds and Crops/R&D Investment Is High
20) Genetically Modified (GM) Ingredients in Processed or Packaged Foods
21) Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals
22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories
23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs
24) Immunotherapy Promises New Approach to Fighting Cancers
25) Technology Discussion—Genes and DNA
26) Technology Discussion—Proteins and Proteomics
27) Technology Discussion—Microarrays
28) Technology Discussion—DNA Chips
29) Technology Discussion—SNPs (“Snips”)
30) Technology Discussion—Combinatorial Chemistry
31) Technology Discussion—Synthetic Biology
32) Technology Discussion—Recombinant DNA
33) Technology Discussion—Polymerase Chain Reaction (PCR)
Biotech & Genetics Industry Statistics
1) Biotech Industry Overview
2) The U.S. Drug Discovery & Approval Process
3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2014
4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2014
5) Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2014
6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2013-2015
7) U.S. Exports & Imports of Pharmaceutical Products: 2009-1st Quarter 2015
8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2007-2023
9) Prescription Drug Expenditures, U.S.: Selected Years, 1960-2023
10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2014
11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2014-2016
12) Global Area of Biotech Crops by Country: 2014
13) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2014
14) Sales By Geographic Area, PhRMA Member Companies: 2013
15) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2014
16) Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2013
INTRODUCTION
HOW TO USE THIS BOOK
CHAPTER 1: MAJOR TRENDS AFFECTING THE BIOTECH & GENETICS INDUSTRY
1) The State of the Biotechnology Industry Today
2) A Short History of Biotechnology
3) Ethanol Production Soared, But U.S. Federal Subsidy Expires
4) Cellulosic Ethanol Makes Slow Commercial Progress
5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
9) Vaccines and Viruses in Drug Delivery
10) New Blockbuster Drugs Come to Market/ Drug Prices Soar/Generics Offer Some Relief
11) Biotech and Orphan Drugs Create New Revenues for Drug Firms
12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs
14) Stem Cells—Multiple Sources Stem from New Technologies
15) Government Support for Stem Cell Research Evolves
16) Stem Cells—Therapeutic Cloning Techniques Advance
17) Stem Cells—A New Era of Tissue Replacement Takes Shape
18) Nanotechnology Converges with Biotech
19) Genetically Modified (GM) Seeds and Crops/R&D Investment Is High
20) Genetically Modified (GM) Ingredients in Processed or Packaged Foods
21) Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals
22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories
23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs
24) Immunotherapy Promises New Approach to Fighting Cancers
25) Technology Discussion—Genes and DNA
26) Technology Discussion—Proteins and Proteomics
27) Technology Discussion—Microarrays
28) Technology Discussion—DNA Chips
29) Technology Discussion—SNPs (“Snips”)
30) Technology Discussion—Combinatorial Chemistry
31) Technology Discussion—Synthetic Biology
32) Technology Discussion—Recombinant DNA
33) Technology Discussion—Polymerase Chain Reaction (PCR)
CHAPTER 2: BIOTECH & GENETICS INDUSTRY STATISTICS
Biotech Industry Overview
The U.S. Drug Discovery & Approval Process
U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2014
U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2014
Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2014
Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2013-2015
U.S. Exports & Imports of Pharmaceutical Products: 2009-1st Quarter 2015
U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2007-2023
Prescription Drug Expenditures, U.S.: Selected Years, 1960-2023
Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2014
Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2014-2016
Global Area of Biotech Crops by Country: 2014
Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2014
Sales By Geographic Area, PhRMA Member Companies: 2013
Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2014
Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2013
CHAPTER 3: IMPORTANT BIOTECH & GENETICS INDUSTRY CONTACTS
(Addresses, Phone Numbers and Internet Sites)
CHAPTER 4: THE BIOTECH 400: WHO THEY ARE AND HOW THEY WERE CHOSEN
Index of Companies Within Industry Groups
Alphabetical Index
Index of U.S. Headquarters Location by State
Index of Non-U.S. Headquarters Location by Country
Individual Profiles on Each of THE BIOTECH 400
Additional Indexes
Index of Hot Spots for Advancement for Women/Minorities
Index by Subsidiaries, Brand Names and Selected Affiliations
A Short Biotech & Genetics Industry Glossary
HOW TO USE THIS BOOK
CHAPTER 1: MAJOR TRENDS AFFECTING THE BIOTECH & GENETICS INDUSTRY
1) The State of the Biotechnology Industry Today
2) A Short History of Biotechnology
3) Ethanol Production Soared, But U.S. Federal Subsidy Expires
4) Cellulosic Ethanol Makes Slow Commercial Progress
5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
9) Vaccines and Viruses in Drug Delivery
10) New Blockbuster Drugs Come to Market/ Drug Prices Soar/Generics Offer Some Relief
11) Biotech and Orphan Drugs Create New Revenues for Drug Firms
12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs
14) Stem Cells—Multiple Sources Stem from New Technologies
15) Government Support for Stem Cell Research Evolves
16) Stem Cells—Therapeutic Cloning Techniques Advance
17) Stem Cells—A New Era of Tissue Replacement Takes Shape
18) Nanotechnology Converges with Biotech
19) Genetically Modified (GM) Seeds and Crops/R&D Investment Is High
20) Genetically Modified (GM) Ingredients in Processed or Packaged Foods
21) Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals
22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories
23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs
24) Immunotherapy Promises New Approach to Fighting Cancers
25) Technology Discussion—Genes and DNA
26) Technology Discussion—Proteins and Proteomics
27) Technology Discussion—Microarrays
28) Technology Discussion—DNA Chips
29) Technology Discussion—SNPs (“Snips”)
30) Technology Discussion—Combinatorial Chemistry
31) Technology Discussion—Synthetic Biology
32) Technology Discussion—Recombinant DNA
33) Technology Discussion—Polymerase Chain Reaction (PCR)
CHAPTER 2: BIOTECH & GENETICS INDUSTRY STATISTICS
Biotech Industry Overview
The U.S. Drug Discovery & Approval Process
U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2014
U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2014
Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2014
Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2013-2015
U.S. Exports & Imports of Pharmaceutical Products: 2009-1st Quarter 2015
U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2007-2023
Prescription Drug Expenditures, U.S.: Selected Years, 1960-2023
Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2014
Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2014-2016
Global Area of Biotech Crops by Country: 2014
Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2014
Sales By Geographic Area, PhRMA Member Companies: 2013
Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2014
Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2013
CHAPTER 3: IMPORTANT BIOTECH & GENETICS INDUSTRY CONTACTS
(Addresses, Phone Numbers and Internet Sites)
CHAPTER 4: THE BIOTECH 400: WHO THEY ARE AND HOW THEY WERE CHOSEN
Index of Companies Within Industry Groups
Alphabetical Index
Index of U.S. Headquarters Location by State
Index of Non-U.S. Headquarters Location by Country
Individual Profiles on Each of THE BIOTECH 400
Additional Indexes
Index of Hot Spots for Advancement for Women/Minorities
Index by Subsidiaries, Brand Names and Selected Affiliations
A Short Biotech & Genetics Industry Glossary
